Self-perception of fracture risk: what can it tell us?

J E Compston, A Wyman, E S Siris, J D Adachi, R Chapurlat, A Díez-Pérez, A Z LaCroix, J W Nieves, J C Netelenbos, J Pfeilschifter, M Rossini, C Roux, K G Saag, S Silverman, N B Watts, S L Greenspan, L March, C L Gregson, E M Dennison, Global Longitudinal Study of Osteoporosis in Women (GLOW) Investigators

Research output: Contribution to journalArticle (Academic Journal)peer-review

6 Citations (Scopus)
242 Downloads (Pure)

Abstract

In this study, we report that self-perception of fracture risk captures some aspect of fracture risk not currently measured using conventional fracture prediction tools and is associated with improved medication uptake. It suggests that adequate appreciation of fracture risk may be beneficial and lead to greater healthcare engagement and treatment.

INTRODUCTION: This study aimed to assess how well self-perception of fracture risk, and fracture risk as estimated by the fracture prediction tool FRAX, related to fracture incidence and uptake and persistence of anti-osteoporosis medication among women participating in the Global Longitudinal study of Osteoporosis in Women (GLOW).

METHODS: GLOW is an international cohort study involving 723 physician practices across 10 countries in Europe, North America and Australia. Aged ≥ 55 years, 60,393 women completed baseline questionnaires detailing medical history, including co-morbidities, fractures and self-perceived fracture risk (SPR). Annual follow-up included self-reported incident fractures and anti-osteoporosis medication (AOM) use. We calculated FRAX risk without bone mineral density measurement.

RESULTS: Of the 39,241 women with at least 1 year of follow-up data, 2132 (5.4%) sustained an incident major osteoporotic fracture over 5 years of follow-up. Within each SPR category, risk of fracture increased as the FRAX categorisation of risk increased. In GLOW, only 11% of women with a lower baseline SPR were taking AOM at baseline, compared with 46% of women with a higher SPR. AOM use tended to increase in the years after a reported fracture. However, women with a lower SPR who were fractured still reported lower AOM rates than women with or without a fracture but had a higher SPR.

CONCLUSIONS: These results suggest that SPR captures some aspect of fracture risk not currently measured using conventional fracture prediction tools and is also associated with improved medication uptake.

Original languageEnglish
JournalOsteoporosis International
Early online date31 Aug 2017
DOIs
Publication statusE-pub ahead of print - 31 Aug 2017

Keywords

  • Journal Article

Fingerprint Dive into the research topics of 'Self-perception of fracture risk: what can it tell us?'. Together they form a unique fingerprint.

Cite this